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Associations of maternal vitamin D, 
ptH and calcium with hypertensive 
disorders of pregnancy and 
associated adverse perinatal 
outcomes: Findings from the Born 
in Bradford cohort study
Gillian santorelli  1, Donald Whitelaw2, Diane Farrar1, Jane West  1 & Debbie A. Lawlor3,4
Vitamin D and parathyroid hormone (ptH) regulate mineral metabolism and are required to maintain 
calcium levels. Vitamin D deficiency is common, particularly during pregnancy, and has been associated 
with hypertensive disorders of pregnancy. We sought to determine whether maternal 25(OH)D, 
PTH and calcium concentrations at 26 weeks gestation are associated with adverse outcomes of 
pregnancy and establish whether these differ by ethnicity. This study included 476 White British and 534 
Pakistani origin mother-offspring pairs from the Born in Bradford cohort study. We used multinomial 
or logistic regression to explore the association between vitamin D, ptH and calcium with gestational 
hypertension (GH), pre-eclampsia (PE), caesarean section (CS), preterm birth (PTB) and small for 
gestational age (SGA). Pakistani women had lower 25(OH)D (median 13.0 vs 36.0 nmol/L), higher PTH 
(median 7.7 vs 3.3 pmol/L) and similar calcium concentrations compared to White British women. In 
Pakistani women, higher concentrations of 25(OH)D were associated with a 60% increased odds of 
GH, and a 37% reduced odds of SGA; PTH was associated with a 45% reduction in the odds of GH. In 
White British women, each 1 SD increase in calcium concentration was associated with a 34% increase 
in developing GH but a 33% reduction in the odds of PTB. Associations with PE and CS were consistent 
with the null. In conclusion, there are ethnic differences in the associations of 25(OH)D, PTH and calcium 
with important perinatal outcomes. Future research would benefit from examining the associations 
of 25(OH)D, PTH and calcium together with a range of perinatal outcomes in order to assess the risk-
benefit action of each.
Low vitamin D levels are a global public health problem1. Vitamin D can be obtained from foods (in the form 
of 25(OH)D2) or dietary supplements, but the main source for most people is synthesised in the skin from sun-
light exposure containing sufficient ultraviolet B (UVB) radiation (25(OH)D3). At latitudes above 37°N, there is 
insufficient sunlight-induced vitamin D synthesis from October to late March; it is therefore essential to obtain 
vitamin D from dietary or supplementary sources during the winter months of northern countries, including the 
UK. People with darker skin are at particular risk of low vitamin D levels, and a number of studies have shown 
that South Asian’s are known to have lower levels of 25-hydroxyvitamin D [25(OH)D] compared to the White 
population2–4.
Vitamin D deficiency is commonly observed in pregnancy1 and has previously been associated with an 
increased risk of hypertensive disorders of pregnancy (gestational hypertension and pre-eclampsia)1,5–9, preterm 
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birth10–14, small for gestational age (SGA) infants14–21 and caesarean birth22–24. Together with parathyroid hor-
mone (PTH), vitamin D is required for the regulation of calcium25; however, despite their close interactions, 
the association between them and adverse perinatal outcomes is still not fully understood. Although calcium 
supplementation during pregnancy seems to reduce the risk of high blood pressure, pre-eclampsia and preterm 
birth26, the effects of vitamin D supplementation are less clear. A recent systematic review found evidence of 
an increase in mean birth weight and a reduced risk of SGA in women receiving vitamin D supplementation; 
however, no associations with other maternal and neonatal outcomes were observed and consequently the evi-
dence was deemed insufficient to guide practice16. To our knowledge no studies have examined the combined 
associations between vitamin D, PTH and calcium levels with hypertensive disorders of pregnancy (HDP) and 
associated adverse perinatal outcomes or explored whether any of these associations differ between ethnic groups. 
Given the known ethnic differences in distributions of pregnancy circulating 25(OH)D27,28, which is a biomarker 
for vitamin D status, it is important to establish whether ethnicity influcences associations of 25(OH)D, PTH and 
calcium with perinatal outcomes. This information could help determine whether thresholds for defining catego-
ries of vitamin D deficiency should differ by ethnicity.
The aims of this study are therefore to (a) determine whether maternal circulating 25(OH)D, PTH and cal-
cium concentrations are associated with gestational hypertension and pre-eclampsia and associated adverse per-
inatal outcomes (caesarean section, preterm birth and small for gestational age) in White British and Pakistani 
women, and (b) establish whether the magnitude or direction of associations between 25(OH)D, PTH and cal-
cium with these outcomes differ between White British and Pakistani women.
Methods
Born in Bradford (BiB) is a longitudinal multi-ethnic cohort study that was established to examine how genetic, 
nutrition, environmental, behavioural and social factors impact on health and development during childhood, and 
subsequently adult life29. Bradford, located at 53.8°N, is the 6th largest city in the UK, is ethnically diverse, and 
has high levels of socio-economic deprivation. Women were recruited to BiB at approximately 26 weeks gestation 
when they attended for oral glucose tolerance testing (OGTT), performed as part of a universal screening pro-
gramme for gestational diabetes. At recruitment, participants gave informed consent, height and weight were meas-
ured and an interview-administered baseline questionnaire completed. A total of 12,450 mothers were recruited 
across 13,773 pregnancies between March 2007 and December 2010, resulting in 13,858 births. Ethics approval 
was granted by Bradford National Health Service Research Ethics Committee (ref 07/H1302/112) on 10 March 
2008, and all research was performed in accordance with relevant guidelines/regulations. A subsample of 1,498 
women who attended for assessment between September 2008 and March 2009 consented to have additional blood 
samples analysed to assess 25(OH)D, PTH and calcium concentrations. We have previously reported findings from 
this cohort regarding associations between these variables and gestational diabetes, which suggested that whilst an 
association with 25(OH)D and PTH was not indicated, the association with calcium warranted further investiga-
tion30. Women were excluded from the present analyses if 25(OH)D, PTH and calcium levels were not measured 
(n = 26), perinatal outcomes were not reported (n = 18) and the baseline questionnaire was not completed (n = 155). 
Women who had a stillbirth (n = 10), a multiple birth (n = 20) or where the type of birth (singleton or multiple) was 
unknown (n = 19), or who were from an ethnic background other than White British or Pakistani (n = 240) were 
also excluded. The final sample size was 1010 (476 White British and 534 Pakistani; see Fig. 1).
outcome measures. We assessed associations of maternal circulating 25(OH) D, PTH and calcium (meas-
ured at 26–28 weeks gestation) with: (1) HDP: gestational hypertension (defined as new onset elevated blood 
pressure after 20 weeks gestation where SPB ≥140 and/or DBP ≥90 on two or more occasions), and pre-eclampsia 
(defined as gestational hypertension with concurrent significant proteinurea ≥1+); (2) caesarean section; (3) pre-
term birth (defined as gestational age at birth <37 weeks); and (4) small for gestational age (SGA), based on the 
2011 UK-WHO charts31.
Mode of birth (vaginal or caesarean section), birthweight and gestational age were extracted from the hos-
pital’s electronic maternity record system. Blood pressure measurements and levels of proteinurea during preg-
nancy were extracted from the maternity notes.
exposures. Our exposures were maternal pregnancy concentrations of serum 25(OH)D, plasma PTH and 
serum calcium. Fasting venous samples were taken at the time of the OGTT (median 26.3 weeks of gestation (IQR 
26.0, 26.9).
Serum 25(OH)D samples were immediately frozen at −80 °C and analysed within 12 months with no interim 
thaw cycles. Serum samples were deproteinized using zinc sulphate and acetonitrile. We used deuterated 25(OH)
D3 [hexadeuterium-25(OH)D3] as an internal standard in all analyses. Chromatographic separation was achieved 
on a Waters Sun Fire C18 column, and detection of 25(OH)D2 and 25(OH)D3 was achieved using Waters 
Micromass Quattro Ultima Platinum Mass Spectrometer. Between-batch coefficients of variation (CoV) were 
5–8% and 4–6% for 25(OH)D2 and 25(OH)D3 respectively. As concentrations of 25(OH)D2 were generally very 
low, total 25(OH)D was calculated by summing 25(OH)D2 and 25(OH)D3 and is presented as nmol/L.
Plasma PTH and serum calcium were analysed promptly at Bradford Royal Infirmary (BRI). 
Chemiluminescence immunoassay was used to measure intact PTH with a manufacturer’s quoted coefficients 
of variation of 7.8% at 4.3 pmol/L and a detection range of 0.265 to 201 pmol/L. Calcium concentrations were 
measured using a colorimetric assay and were adjusted for albumin; values are presented as mmol/L.
Confounders. We adjusted our analyses for a number of confounders with 25(OH)D levels that have been 
identified by previous research. Information on maternal age, ethnicity, mother’s highest educational qualifi-
cations (defined as less than A-level and A-level and above. A-levels are subject-specific qualifications taken by 
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students aged 16–18 in England, Wales and Northern Ireland, and are the main school leaving qualifications 
in these countries) and in receipt of means-tested benefits (which aim to give extra support to individuals who 
can demonstrate that their income and capital are below a certain level) as proxy measures for socio-economic 
position, smoking during pregnancy, vitamin D supplementation (at least once a week) and physical activity 
(estimated using the General Practice Physical Activity Questionnaire (GPPAQ)32) were obtained from the base-
line questionnaire. Early pregnancy BMI was derived from maternal height and weight measured at pregnancy 
booking (~12 weeks gestation). Sunshine exposure was estimated in the three months before the samples were 
taken using data from the Bradford station of the UK meteorological office33,34.
statistical analysis. The distribution of outcomes and risk factors for both ethnic groups are presented as 
frequency (percentage), mean (SD) or median (IQR). Associations of 25(OH)D, PTH and calcium with gesta-
tional hypertension, pre-eclampsia and associated adverse outcomes were assessed using multinomial or logistic 
regression with the exposure as a continuous variable. Two models were considered for each outcome: model 
1 was unadjusted, and model 2 was adjusted for the confounders described above. The physical activity ques-
tionnaire has four categories: inactive, moderately inactive, moderately active and active; however, due to low 
numbers in the ‘active’ category, this was merged with ‘moderately active’ for the analysis. Associations between 
the exposures and outcomes are presented as odds ratios per 1 standard deviation (SD) increase. The analysis was 
done for all women, and for White British and Pakistani women separately and tested for any differences in asso-
ciations between the ethnic groups (i.e. tested for an interaction between ethnicity and exposure). All analyses 
were performed using STATA/SE software (Stata/SE 13.1 for Windows, StataCorp LP, College Station, TX, USA).
ethics approval. Ethics approval was granted by Bradford National Health Service Research Ethics 
Committee (ref 07/H1302/112) on 10 March 2008.
Results
Overall and ethnic differences in maternal exposures with gestational hypertension, pre-eclampsia 
and associated adverse perinatal outcomes. Table 1 shows the distribution of outcomes, exposures 
and maternal characteristics. Compared to White British women, Pakistani women were slightly older (27.6 vs 
26.4 years), had a lower BMI (25.2 vs 27.0 kg/m2), were less likely to smoke during pregnancy (3.8% vs 34.2%), 
were more likely to be in receipt of means-tested benefits (47.2 vs 37.0%) and reported lower physical activity 
levels (93.3% vs 76.0% inactive or moderately inactive). On average, Pakistani women had lower median levels 
of 25(OH)D (13.0 vs 36.0 nmol/mL2) and higher levels of PTH (7.9 vs 3.3 pmol/L2) than White British women; 
both groups had similar distributions of calcium (see Fig. 2). A greater proportion of White British women devel-
oped gestational hypertension (12.0% vs 5.4%) and pre-eclampsia (3.4% vs 1.7%), and had a caesarean (22.5% vs 
19.9%) or preterm birth (6.5% vs 4.5%) compared to Pakistani women. Conversely, delivery of a small for gesta-
tional age baby was more common in Pakistani women (19.9% vs 8.6%).
Figure 1. Study flow chart.
www.nature.com/scientificreports/
4Scientific RepoRts |          (2019) 9:1205  | https://doi.org/10.1038/s41598-018-37600-9
Associations between 25(OH)D, PTH and calcium with gestational hypertension, pre-eclampsia 
and associated adverse perinatal outcomes. Adjusted (Model 2) associations of each exposure with 
outcomes in White British and Pakistani mother-offspring pairs are shown in Table 2, and Figs 3 and 4, with the 
unadjusted (Model 1) results in the supplementary material. In the adjusted analyses, higher concentrations of 
25(OH)D in Pakistani women were associated with a 60% increased odds of developing gestational hypertension, 
whereas higher PTH levels were associated with a 45% relative reduction, and there was evidence of a statistical 
interaction between the ethnic groups (p < 0.01 and p = 0.10 respectively). 25(OH)D was also associated with 
a reduced odds of SGA and higher calcium concentrations were associated with gestational hypertension but a 
reduced odds of preterm birth in White British but not Pakistani women; however, there was no strong statistical 
support for any ethnic differences, with p-values for interaction with ethnicity being ≥1.0. Associations with 
caesarean delivery were broadly consistent with the null.
Discussion
Main findings. We found that at 26 weeks gestation, White British women had markedly higher levels of 
25(OH)D levels, lower PTH and similar calcium levels compared to Pakistani women. We found evidence for 
ethnic differences in associations between maternal 25(OH)D and PTH with gestational hypertension. Where 
point estimates differed between the two groups, the directions of these with respect to clinical outcomes were 
inconsistent. For example, our results suggest higher average 25(OH)D could be detrimental to Pakistani women 
by increasing their risk of gestational hypertension but beneficial in reducing their risk of SGA. Higher calcium 
concentrations were associated with an increased risk of gestational hypertension but reduced the risk of preterm 
birth in White British women.
strengths and limitations. The strengths of our study include its prospective bi-ethnic cohort design, 
direct measurement of 25(OH)D, PTH and calcium levels and detailed information on a number of potential 
confounders. Limitations are that due to overall small numbers, and hence relatively few cases for the outcomes 
Maternal characteristics and perinatal outcomes All N = 1010 White British N = 476 Pakistani N = 534
Age (years)* 27.0 ± 5.5 26.4 ± 6.3 27.6 ± 5.3
BMI at 12 weeks gestation* 26.0 ± 5.8 27.0 ± 6.2 25.2 ± 5.3
Smoked during pregnancy
   No 827 (81.9) 313 (65.8) 514 (96.3)
   Yes 183 (18.1) 163 (34.2) 20 (3.8)
In receipt of means-tested benefits
   No 582 (57.6) 300 (62.4) 282 (52.8)
   Yes 428 (42.4) 176 (37.0) 252 (47.2)
Maternal education
   Less than A level 627 (62.1) 304 (63.9) 323 (60.5)
   A level and above 383 (37.9) 172 (36.1) 211 (39.5)
Physical activity level
   Inactive 668 (66.1) 242 (50.8) 426 (79.8)
   Moderately inactive 181 (19.0) 120 (25.2) 72 (13.5)
   Moderately active 94 (9.3) 70 (14.7) 24 (4.5)
   Active 56 (5.5) 44 (9.2) 12 (2.3)
Vitamin D supplementation
   No 835 (82.7) 389 (81.7) 446 (83.5)
   Yes 175 (17.3) 87 (18.3) 88 (16.5)
   Sunshine, hours per 3 mths† 248.9 (161.9–315.7) 258.5 (164.2, 322.6) 237.7 (159.5, 308.9)
   25(OH)D, nmol/mL† 22.6 (12.0–40.8) 36.0 (26.0–55.5) 13.0 (8.8–20.3)
Vitamin D status
   Deficient 598 (61.5) 160 (34.8) 438 (85.4)
   Insufficient 196 (20.1) 152 (33.0) 44 (8.6)
   Adequate 179 (18.4) 148 (32.2) 31 (6.0)
PTH, pmol/L† 5.0 (3.2–8.2) 3.3 (2.4–4.5) 7.9 (5.5–11.3)
Calcium, mmol/L† 2.25 (2.20–2.29) 2.25 (2.22–2.30) 2.24 (2.19–2.28)
Gestational hypertension 86 (8.5) 57 (12.0) 29 (5.4)
Pre-eclampsia 25 (2.5) 16 (3.4) 9 (1.7)
Caesarean birth 213 (21.1) 107 (22.5) 106 (19.9)
Preterm birth (<37 wks) 55 (5.5) 31 (6.5) 24 (4.5)
Small for gestational age 147 (14.6) 41 (8.6) 106 (19.9)
Table 1. Maternal characteristics and perinatal outcomes for all pregnancies and by ethnic group (White British 
and Pakistani). Values are n (%) unless otherwise indicated. *Mean (SD); †Median (IQR).
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examined, we have limited statistical power, especially when considering ethnic differences, however our study 
is able to show potential areas where investigation should be directed. Related to the relatively small sample sizes 
we were unable to explore possible non-linear associations of 25(OH)D, PTH and calcium with our outcomes. 
It is known that concentrations of 25(OH)D fluctuate over time; however we were only able to assess it once, at 
around 26 weeks gestation. It would have been desirable to have also had data at earlier and later time-points in 
order to evaluate change over time, as it is possible that concentrations at different stages of fetal development 
or that change during pregnancy is important in the development of adverse perinatal outcomes. Due to a lack 
of diet-related data, we were not able to adjust for this in our analyses. However, we have directly measured total 
plasma 25(OH)D concentration, and have accounted for sunshine exposure and vitamin D supplementation in 
the analyses. As few foods are naturally rich in vitamin D, it is unlikely that including diet in our analyses would 
have had an impact. Our results are from White British and Pakistani origin women resident in the UK and may 
therefore not be generalisable to other White or South Asian ethnic groups. However, in stratifying our analyses 
by ethnic group we were able to observe the effect of the exposures on outcomes in the majority ethnic group in 
the UK (White British) and in Pakistani-origin women, who account for a significant proportion of the popula-
tion in a number of UK towns and cities.
Interpretation. There is growing evidence that low levels of 25(OH)D can adversely affect cardiometa-
bolic health in adults including associations with both hypertension and insulin resistance35,36. In pregnancy, 
there is evidence to suggest an association between 25(OH)D and the pathophysiology of pre-eclampsia8. One 
recent study reported similar 25-hydroxyvitamin D3 levels in normotensive pregnant women and women with 
pre-eclampsia, but higher levels of vitamin D metabolites and impaired placental uptake of 25-hydroxyvitamin 
Figure 2. Box and scatter plots of maternal circulating 25(OH)D, PTH and calcium concentrations in White 
British and Pakistani women.
www.nature.com/scientificreports/
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D3 in women with pre-eclampsia37, suggesting vitamin D metabolism may influence physiological processes in 
a number of ways.
Pre-eclampsia is associated with increased maternal and infant mortality and morbidity therefore interven-
tions to ameliorate these risks urgently required. Vitamin D supplementation to improve outcomes including 
reducing the risk of pre-eclampsia continues to attract investigation. A recent systematic review included 43 trials 
and identified a further 35 registered trials, unfortunately only eight of the 43 included trials were considered 
at low risk of bias16. Conflicting with data from previous observational studies showing an inverse relationship 
with vitamin D levels and pre-eclampsia, we demonstrated a positive association and the review of Vitamin D 
supplementation found no evidence of an effect on risk of pre-eclampsia or gestational hypertension. Reasons for 
inconsistencies between trials and observational studies investigating associations are unclear, but may include: 
Outcome
aOR† (95% CI) for each outcome per 1 SD of exposure
PInteraction‡All (n = 978)
White British 
(n = 462)
Pakistani 
(n = 516)
HDP*
25(OH)D
   Gestational hypertension 1.2014 (0.94–1.54) 0.81 (0.55–1.21) 1.60 (1.00–2.55) <0.001
   Pre-eclampsia 1.33 (0.91–1.94) 1.18 (0.69–1.99) 1.88 (0.78–4.50) 0.58
PTH
   Gestational hypertension 0.55 (0.37–0.83) 0.96 (0.43–2.14) 0.55 (0.30–1.01) 0.10
   Pre-eclampsia 1.05 (0.66–1.66) 1.02 (0.25–4.21) 1.31 (0.81–2.11) 0.87
Calcium
   Gestational hypertension 1.35 (1.08–1.21) 1.34 (1.01–1.76) 1.17 (0.78–1.76) 0.70
   Pre-eclampsia 0.92 (0.60–1.39) 0.92 (0.55–1.56) 0.85 (0.40–1.81) 0.95
Caesarean birth
25(OH)D 1.02 (0.86–1.21) 0.97 (0.76–1.25) 1.17 (0.83–1.66) 0.31
PTH 0.93 (0.77–1.11) 0.80 (0.44–1.45) 0.93 (0.75–1.16) 0.99
Calcium 0.94 (0.80–1.10) 0.906(0.77–1.20) 0.94 (0.75–1.18) 0.77
Preterm birth
25(OH)D 1.16 (0.86–1.55) 1.06 (0.72–1.57) 1.10 (0.53–2.28) 0.78
PTH 1.11 (0.86–1.45) 1.73 (0.71–4.18) 1.07 (0.85–1.54) 0.60
Calcium 0.84 (0.63–1.12) 0.67 (0.44–1.01) 1.07 (0.69–1.68) 0.12
Small for gestational age
25(OH)D 0.58 (0.44–0.77) 0.93 (0.63–1.37) 0.63 (0.37–1.04) 0.37
PTH 1.30 (1.10–1.53) 0.59 (0.21–1.68) 1.14 (0.95–1.37) 0.31
Calcium 1.08 (0.90–1.30) 1.24 (0.88–1.74) 1.11 (0.89–1.40) 0.67
Table 2. Adjusted associations of maternal circulating 25(OH)D, PTH and calcium with hypertensive disorders 
of pregnancy (HDP) and adverse associated outcomes overall and stratified by ethnicity. *Hypertensive 
disorders of pregnancy; normotensive is the reference category. †Adjusted for maternal age, BMI, highest 
educational attainment, smoking status in pregnancy, in receipt of benefits, physical activity levels, hours of 
sunshine and vitamin D supplementation. ‡P-value for interaction with ethnicity.
Figure 3. Adjusted odds ratios with 95% CI for associations between a 1 SD increase in maternal circulating 
25(OH)D, PTH and calcium with hypertensive disorders of pregnancy. Gestational hypertension: ● White 
British women ▲ Pakistani women. Pre-eclampsia: ○ White British women △ Pakistani women.
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the possibility that there are different effects associated with naturally occurring vitamin D synthesised from 
sunlight compared to vitamin D taken as a supplement; different effects from natural or artificial vitamin D 
metabolites; heterogeneity of included trials in the review and variation in the definition of pre-eclampsia across 
trials or effects from variables not measured in observational studies. Our study and the findings of two other 
reviews share similarities in that we found higher concentrations of 25(OH)D reduced the risk of SGA16,17 and an 
increase in mean birth weight16 with supplementation. Low vitamin D may lead to low calcium levels which may 
in turn lead to increased vasoconstriction and hypertension by stimulating PTH or renin release, and calcium has 
previously been shown to be inversely related to pre-eclampsia38. Strong evidence from high quality trials suggests 
a beneficial effect on high blood pressure and pre-eclampsia from calcium supplementation (at least 1 g/day) in 
pregnancy, but an increase in the risk of HELLP (haemolysis, elevated liver enzymes and low platelets) syndrome; 
the authors suggest this latter inconsistent finding may result from the control of blood pressure without treat-
ment of the underlying pre-eclamptic process26. Conversely we found a positive association between calcium and 
Figure 4. Adjusted odds ratios with 95% CI for associations between a 1 SD increase in maternal circulating 
25(OH)D, PTH and calcium with caesarean section, preterm birth and small for gestational age. ● White 
British women ▲ Pakistani women.
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gestational hypertension, which may be a result of small numbers and consequently few events but may also be 
due to the relatively small change in each SD of calcium in unsupplemented women in our study compared to the 
large differences in calcium levels from supplementation.
Conclusion
Our findings indicate ethnic differences exist in the associations between 25(OH)D, PTH and calcium with HDP 
and associated adverse perinatal outcomes, and that the directions of these associations were inconsistent with 
respect to clinical importance. The potential combination for benefit and harm for different outcomes highlights 
the importance of examining several related exposure and outcomes in one study.
Data Availability statement
Data can be made available upon request.
References
 1. Palacios, C. & Gonzalez, L. Is vitamin D deficiency a major global public health problem? The Journal of steroid biochemistry and 
molecular biology 144 Pt A, 138–145, https://doi.org/10.1016/j.jsbmb.2013.11.003 (2014).
 2. Darling, A. L. et al. Vitamin D deficiency in UK South Asian Women of childbearing age: a comparative longitudinal investigation 
with UK Caucasian women. Osteoporosis international: a journal established as result of cooperation between the European Foundation 
for Osteoporosis and the National Osteoporosis Foundation of the USA 24, 477–488, https://doi.org/10.1007/s00198-012-1973-2 
(2013).
 3. Kift, R. et al. Lifestyle factors including less cutaneous sun exposure contribute to starkly lower vitamin D levels in U.K. South Asians 
compared with the white population. The British journal of dermatology 169, 1272–1278, https://doi.org/10.1111/bjd.12518 (2013).
 4. Patel, J. V. et al. Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study. International journal of 
cardiology 167, 2172–2176, https://doi.org/10.1016/j.ijcard.2012.05.081 (2013).
 5. Bodnar, L. M. et al. Maternal vitamin D deficiency increases the risk of preeclampsia. The Journal of clinical endocrinology and 
metabolism 92, 3517–3522, https://doi.org/10.1210/jc.2007-0718 (2007).
 6. Burris, H. H. et al. Vitamin D status and hypertensive disorders in pregnancy. Annals of epidemiology 24, 399–403 e391, https://doi.
org/10.1016/j.annepidem.2014.02.001 (2014).
 7. Hypponen, E. et al. Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis. Annals of nutrition & 
metabolism 63, 331–340, https://doi.org/10.1159/000358338 (2013).
 8. Kawtar, N., Wafae, R., Saadia, J. & Ouafa, M. Vitamin D and Pre-eclampsia. Gynecol Obstet 6 (2016).
 9. Tabesh, M., Salehi-Abargouei, A., Tabesh, M. & Esmaillzadeh, A. Maternal vitamin D status and risk of pre-eclampsia: a systematic 
review and meta-analysis. The Journal of clinical endocrinology and metabolism 98, 3165–3173, https://doi.org/10.1210/jc.2013-1257 
(2013).
 10. Amegah, A. K., Klevor, M. K. & Wagner, C. L. Maternal vitamin D insufficiency and risk of adverse pregnancy and birth outcomes: 
A systematic review and meta-analysis of longitudinal studies. PLoS One 12, e0173605, https://doi.org/10.1371/journal.
pone.0173605 (2017).
 11. McDonnell, S. L. et al. Maternal 25(OH)D concentrations >/=40 ng/mL associated with 60% lower preterm birth risk among 
general obstetrical patients at an urban medical center. PLoS One 12, e0180483, https://doi.org/10.1371/journal.pone.0180483 
(2017).
 12. Qin, L. L., Lu, F. G., Yang, S. H., Xu, H. L. & Luo, B. A. Does Maternal Vitamin D Deficiency Increase the Risk of Preterm Birth: A 
Meta-Analysis of Observational Studies. Nutrients 8, https://doi.org/10.3390/nu8050301 (2016).
 13. Tabatabaei, N. et al. Maternal Vitamin D Insufficiency Early in Pregnancy Is Associated with Increased Risk of Preterm Birth in 
Ethnic Minority Women in Canada. The Journal of nutrition, https://doi.org/10.3945/jn.116.241216 (2017).
 14. Wei, S. Q., Qi, H. P., Luo, Z. C. & Fraser, W. D. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and 
meta-analysis. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal 
Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 26, 889–899, https://doi.
org/10.3109/14767058.2013.765849 (2013).
 15. Aghajafari, F. et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: 
systematic review and meta-analysis of observational studies. Bmj 346, f1169, https://doi.org/10.1136/bmj.f1169 (2013).
 16. Roth, D. E. et al. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials. 
Bmj 359, j5237, https://doi.org/10.1136/bmj.j5237 (2017).
 17. Bi, W. G. et al. Association Between Vitamin D Supplementation During Pregnancy and Offspring Growth, Morbidity, and 
Mortality: A Systematic Review and Meta-analysis. JAMA pediatrics, https://doi.org/10.1001/jamapediatrics.2018.0302 (2018).
 18. Bodnar, L. M. et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in 
white women. The Journal of nutrition 140, 999–1006, https://doi.org/10.3945/jn.109.119636 (2010).
 19. Burris, H. H. et al. Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants. Annals 
of epidemiology 22, 581–586, https://doi.org/10.1016/j.annepidem.2012.04.015 (2012).
 20. Chen, Y. H. et al. Maternal vitamin D deficiency during pregnancy elevates the risks of small for gestational age and low birth weight 
infants in Chinese population. The Journal of clinical endocrinology and metabolism 100, 1912–1919, https://doi.org/10.1210/
jc.2014-4407 (2015).
 21. Leffelaar, E. R., Vrijkotte, T. G. & van Eijsden, M. Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: 
results of the multi-ethnic Amsterdam Born Children and their Development cohort. The British journal of nutrition 104, 108–117, 
https://doi.org/10.1017/S000711451000022X (2010).
 22. Merewood, A., Mehta, S. D., Chen, T. C., Bauchner, H. & Holick, M. F. Association between vitamin D deficiency and primary 
cesarean section. The Journal of clinical endocrinology and metabolism 94, 940–945, https://doi.org/10.1210/jc.2008-1217 (2009).
 23. Rodriguez, A. et al. Associations of maternal circulating 25-hydroxyvitamin D3 concentration with pregnancy and birth outcomes. 
BJOG: an international journal of obstetrics and gynaecology 122, 1695–1704, https://doi.org/10.1111/1471-0528.13074 (2015).
 24. Scholl, T. O., Chen, X. & Stein, P. Maternal vitamin D status and delivery by cesarean. Nutrients 4, 319–330, https://doi.org/10.3390/
nu4040319 (2012).
 25. Holick, M. F. & C. C. T. Vitamin D deficiency: a worldwide problem with health consequences. Am J clin nutrition 87, 1080S–1086S 
(2008).
 26. Hofmeyr, G. J., Lawrie, T. A., Atallah, Á. N., Duley, L. & Torloni, M. R. Calcium supplementation during pregnancy for preventing 
hypertensive disorders and related problems. Cochrane Database Syst Revs (2014).
 27. Yu, C. K., Sykes, L., Sethi, M., Teoh, T. G. & Robinson, S. Vitamin D deficiency and supplementation during pregnancy. Clinical 
endocrinology 70, 685–690, https://doi.org/10.1111/j.1365-2265.2008.03403.x (2009).
 28. Eggemoen, Å. R. et al. Vitamin D deficiency and supplementation in pregnancy in a multiethnic population-based cohort. BMC 
Pregnancy Childbirth 16, 7 (2016).
www.nature.com/scientificreports/
9Scientific RepoRts |          (2019) 9:1205  | https://doi.org/10.1038/s41598-018-37600-9
 29. Wright, J. et al. Cohort Profile: the Born in Bradford multi-ethnic family cohort study. International journal of epidemiology 42, 
978–991, https://doi.org/10.1093/ije/dys112 (2013).
 30. Whitelaw, D. C. et al. Associations of circulating calcium and 25-hydroxyvitamin D with glucose metabolism in pregnancy: a cross-
sectional study in European and South Asian women. The Journal of clinical endocrinology and metabolism 99, 938–946, https://doi.
org/10.1210/jc.2013-2896 (2014).
 31. Cole, T. J., Williams, A. F., Wright, C. M. & Group, R. G. C. E. Revised birth centiles for weight, length and head circumference in the 
UK-WHO growth charts. Annals of human biology 38, 7–11, https://doi.org/10.3109/03014460.2011.544139 (2011).
 32. Department of Health. General Practise Physical Activity Questionnaire (2009).
 33. Met Office, http:/www.metoffice.gov.uk/climate/uk/stationdata/bradforddata.
 34. Sayers, A., Tilling, K., Boucher, B. J., Noonan, K. & Tobias, J. H. Predicting ambient ultraviolet from routine meteorological data; its 
potential use as an instrumental variable for vitamin D status in pregnancy in a longitudinal birth cohort in the UK. International 
journal of epidemiology 38, 1681–1688, https://doi.org/10.1093/ije/dyp237 (2009).
 35. Forman, J. P. et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 1063–1069, https://doi.
org/10.1161/HYPERTENSIONAHA.107.087288 (2007).
 36. Forouhi, N. G., Luan, J., Cooper, A., Boucher, B. J. & Wareham, N. J. Baseline serum 25-hydroxy vitamin d is predictive of future 
glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57, 2619–2625, 
https://doi.org/10.2337/db08-0593 (2008).
 37. Tamblyn, J. A. et al. Dysregulation of maternal and placental vitamin D metabolism in preeclampsia. Placenta 50, 70–77, https://doi.
org/10.1016/j.placenta.2016.12.019 (2017).
 38. Belizán, J. M., Villar, J. & Repke, J. The relationship between calcium intake and pregnancy-induced hypertension: Up-to-date 
evidence. Am J Obstet Gynecol 158, 898–902, https://doi.org/10.1016/0002-9378(88)90091-9 (1988).
Acknowledgements
Born in Bradford is only possible because of the enthusiasm and commitment of all the children and parents in 
Born in Bradford. We thank all the participants, health professionals and researchers who have made Born in 
Bradford happen. BiB receives core infrastructure funding from the Wellcome Trust (WT101597M) and a joint 
grant from the UK Medical Research Council (MRC) and Economic and Social Science Research Council (ESRC) 
(MR/N024397/1). Laboratory analysis of plasma vitamin D, PTH and calcium levels was supported by a Diabetes 
UK project grant (08/0003672). DF is supported by a Post-doctoral NIHR fellowship. DAL works in a unit that 
received UK MRC funding (MC_UU_10213/5) and is a NIHR senior investigator (NF-SI-0611-10196).
Author Contributions
Donald Whitelaw (D.W.) and Gillian Santorelli (G.S.) conceived the study idea. G.S. and D.A. Lawlor (D.A.L.) 
wrote the analysis plan. G.S. analysed the data and wrote the first draft of the manuscript. G.S., D.W., Diane Farrar 
(D.F.), Jane West (J.W.) and D.A.L. contributed to further drafts and have read and approved the final manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-37600-9.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
